Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nebiat Gebreselassie

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The European Respiratory Journal|November 13, 2020
A global strategy for tuberculosis research and innovationNebiat Gebreselassie, Tereza Kasaeva, Matteo Zignol
The European Respiratory Journal|March 20, 2019
Tuberculosis research questions identified through the WHO policy guideline development processNebiat Gebreselassie, Dennis Falzon, Matteo Zignol, et al.
The Lancet. Infectious Diseases|February 5, 2019
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaborationJohan Vekemans, Nebiat Gebreselassie, Matteo Zignol, et al.
The European Respiratory Journal|March 22, 2020
The case for assessing the full value of new tuberculosis vaccinesNebiat Gebreselassie, Raymond Hutubessy, Johan Vekemans, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Tuberculosis research and development: seeding the futureChristian Lienhardt, Alimuddin Zumla, Nebiat Gebreselassie, et al.
Plos One|June 26, 2018
A bibliometric analysis of tuberculosis research, 2007-2016Vaidehi Nafade, Madlen Nash, Sophie Huddart, et al.
Nutrients|July 24, 2019
Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1Catharina Missailidis, Nikolaj Sørensen, Senait Ashenafi, et al.
Nutrients|January 13, 2019
Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled TrialSenait Ashenafi, Wondwossen Amogne, Endale Kassa, et al.
Plos Medicine|July 11, 2023
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling studyAllison Portnoy, Jean-Louis Arcand, Rebecca A Clark, et al.
BMJ Global Health|July 12, 2023
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesAllison Portnoy, Rebecca A Clark, Chathika K Weerasuriya, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The European Respiratory Journal|November 13, 2020
A global strategy for tuberculosis research and innovationNebiat Gebreselassie, Tereza Kasaeva, Matteo Zignol
The European Respiratory Journal|March 20, 2019
Tuberculosis research questions identified through the WHO policy guideline development processNebiat Gebreselassie, Dennis Falzon, Matteo Zignol, et al.
The Lancet. Infectious Diseases|February 5, 2019
A new tuberculosis vaccine: breakthrough, challenges, and a call for collaborationJohan Vekemans, Nebiat Gebreselassie, Matteo Zignol, et al.
The European Respiratory Journal|March 22, 2020
The case for assessing the full value of new tuberculosis vaccinesNebiat Gebreselassie, Raymond Hutubessy, Johan Vekemans, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Tuberculosis research and development: seeding the futureChristian Lienhardt, Alimuddin Zumla, Nebiat Gebreselassie, et al.
Plos One|June 26, 2018
A bibliometric analysis of tuberculosis research, 2007-2016Vaidehi Nafade, Madlen Nash, Sophie Huddart, et al.
Nutrients|July 24, 2019
Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1Catharina Missailidis, Nikolaj Sørensen, Senait Ashenafi, et al.
Nutrients|January 13, 2019
Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled TrialSenait Ashenafi, Wondwossen Amogne, Endale Kassa, et al.
Plos Medicine|July 11, 2023
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling studyAllison Portnoy, Jean-Louis Arcand, Rebecca A Clark, et al.
BMJ Global Health|July 12, 2023
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesAllison Portnoy, Rebecca A Clark, Chathika K Weerasuriya, et al.
Pageof 2